A. Zabetian

发表

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.

Foreman, Michael K. Freeman, T. Moffitt, 2013, JAMA.

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Bernadette A. Thomas, Alan D. Lopez, Michael K. Freeman, 2012, The Lancet.

Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis.

K. Narayan, Mohammed K. Ali, A. Zabetian, 2012, Diabetes research and clinical practice.

Diabetes in the Middle East and North Africa.

K. Narayan, Mohammed K. Ali, A. Zabetian, 2013, Diabetes research and clinical practice.

Seasonal variability of serum lipids in adults: Tehran Lipid and Glucose Study.

A. Zabetian, F. Hadaegh, F. Azizi, 2006, The Medical journal of Malaysia.

The prospective association of general and central obesity variables with incident type 2 diabetes in adults, Tehran lipid and glucose study.

A. Zabetian, F. Azizi, F. Hadaegh, 2007, Diabetes research and clinical practice.

Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men--a 3.6-year prospective study.

A. Zabetian, F. Hadaegh, F. Azizi, 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.

A. Zabetian, F. Azizi, F. Hadaegh, 2007, Diabetes research and clinical practice.

ANTHROPOMETRIC PARAMETERS AS HELPFUL FACTORS FOR PREDICTION OF TYPE 2 DIABETES ONSET, TEHRAN LIPID AND GLUCOSE STUDY

A. Zabetian, F. Azizi, F. Hadaegh, 2005 .

Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials.

A. Garg, A. Zabetian, B. Ferket, 2016, Journal of the American Society of Nephrology : JASN.

Plasma and urine biomarkers in chronic kidney disease: closer to clinical application

A. Zabetian, S. Coca, 2021, Current opinion in nephrology and hypertension.

Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population.

A. Zabetian, A. Ghasemi, F. Azizi, 2009, Annals of the Academy of Medicine, Singapore.

RELATIONSHIP BETWEEN METABOLIC SYNDROME AND CORONARY HEART DISEASE IN RANIAN POPULATION; THE TEHRAN LIPID AND GLUCOSE STUDY

A. Zabetian, A. Fereydoun, H. Farzad, 2008 .

Real World Evidence and Clinical Utility of KidneyIntelX on Patients With Early-Stage Diabetic Kidney Disease: Interim Results on Decision Impact and Outcomes

A. Zabetian, G. Nadkarni, S. Coca, 2022, Journal of primary care & community health.

Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study.

A. Zabetian, A. Ghasemi, F. Azizi, 2007, Diabetes research and clinical practice.

Excess cost burden of diabetes in Southern India: a clinic-based, comparative cost-of-illness study

V. Mohan, A. Zabetian, M. Deepa, 2016, Global health, epidemiology and genomics.

Cardiometabolic Risk Factor Changes Observed in Diabetes Prevention Programs in US Settings: A Systematic Review and Meta-analysis

Mohammed K. Ali, A. Zabetian, E. Gregg, 2016, PLoS medicine.

Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity.

R. Kelishadi, A. Esteghamati, A. Zabetian, 2010, Archives of Iranian medicine.

Metabolic syndrome in normal-weight Iranian adults

A. Zabetian, F. Azizi, F. Hadaegh, 2006, Annals of Saudi medicine.

Global rural diabetes prevalence: a systematic review and meta-analysis covering 1990-2012.

K. Narayan, Mohammed K. Ali, A. Zabetian, 2014, Diabetes research and clinical practice.

Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population

A. Zabetian, D. Khalili, P. Sarbakhsh, 2009, International Journal of Obesity.

The need for risk stratification in type 2 diabetes and chronic kidney disease: Proposed clinical value of KidneyIntelX

T. McLaughlin, A. Zabetian, G. Nadkarni, 2023, Diabetic Nephropathy.

A new approach to compare the predictive power of metabolic syndrome defined by a joint interim statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran

A. Zabetian, D. Khalili, F. Hadaegh, 2010, Journal of Epidemiology & Community Health.

San Antonio heart study diabetes prediction model applicable to a Middle Eastern population? Tehran glucose and lipid study

A. Zabetian, F. Azizi, F. Hadaegh, 2010, International Journal of Public Health.

Impact of hip circumference and height on incident diabetes: results from 6‐year follow‐up in the Tehran Lipid and Glucose Study

A. Zabetian, F. Hadaegh, M. Bozorgmanesh, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study

A. Zabetian, F. Azizi, P. Sarbakhsh, 2009, BMC public health.

Impact of hip circumference and height on incident diabetes: results from 6‐year follow‐up in the Tehran Lipid and Glucose Study

A. Zabetian, F. Hadaegh, M. Bozorgmanesh, 2011, Diabetic medicine : a journal of the British Diabetic Association.